Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Simvastatin (SIM) is widely prescribed to treat hyperlipidemia, despite its limitations, such as a short half-life and low oral bioavailability. To overcome these drawbacks, the development of a controlled-release formulation is desirable. This study aims to develop a microparticulate system based on cellulose acetate (ACT) obtained from Agave sisalana Perrine to promote a controlled SIM release. SIM-loaded microparticles (SMP) were prepared using the solvent emulsification-evaporation method. Several parameters were evaluated, including particle size, surface charge, morphology, encapsulation efficiency, thermochemical characteristics, crystallinity, and in vitro release profile. ACT exhibited favorable flow properties after acetylation, with a degree of substitution values superior to 2.5, as confirmed by both the chemical route and H-NMR, indicating the formation of cellulose triacetate. The obtained SMP were spherical with an average size ranging from 1842 to 1857 nm, a zeta potential of −4.45 mV, and a high SIM incorporation efficiency (98%). Thermal and XRD analyses revealed that SIM was homogeneously dispersed into the polymeric matrix in its amorphous state. In vitro studies using dialysis bags revealed that the controlled SIM release from microparticles was higher under simulated intestinal conditions and followed the Higuchi kinetic model. Our results suggest that ACT-based microparticles are a promising system for SIM delivery, which can improve its bioavailability, and result in better patient compliance.

Details

Title
Cellulose Acetate Microparticles Synthesized from Agave sisalana Perrine for Controlled Release of Simvastatin
Author
Larissa Pereira Alves 1   VIAFID ORCID Logo  ; da Silva Oliveira, Kevin 1 ; Ana Cláudia Gonçalves dos Santos 2 ; Demis Ferreira de Melo 1   VIAFID ORCID Logo  ; Lívia Maria Coelho de Carvalho Moreira 1 ; João Augusto Oshiro Junior 3   VIAFID ORCID Logo  ; Dayanne Tomaz Casimiro da Silva 1   VIAFID ORCID Logo  ; Airlla Laana de Medeiros Cavalcanti 2 ; Bolívar Ponciano Goulart de Lima Damasceno 1   VIAFID ORCID Logo 

 Graduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil; [email protected] (L.P.A.); [email protected] (K.d.S.O.); [email protected] (D.F.d.M.); [email protected] (L.M.C.d.C.M.); [email protected] (J.A.O.J.); [email protected] (D.T.C.d.S.); [email protected] (B.P.G.d.L.D.); Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Paraíba State University, Campina Grande 58429-600, PB, Brazil; [email protected] 
 Laboratory of Development and Characterization of Pharmaceutical Products, Department of Pharmacy, Paraíba State University, Campina Grande 58429-600, PB, Brazil; [email protected] 
 Graduate Program of Pharmaceutical Sciences, Paraíba State University, Campina Grande 58429-600, PB, Brazil; [email protected] (L.P.A.); [email protected] (K.d.S.O.); [email protected] (D.F.d.M.); [email protected] (L.M.C.d.C.M.); [email protected] (J.A.O.J.); [email protected] (D.T.C.d.S.); [email protected] (B.P.G.d.L.D.) 
First page
1898
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
20734360
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3079107797
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.